Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-24-004330
Filing Date
2024-03-29
Accepted
2024-03-29 08:21:41
Documents
5
Effectiveness Date
2024-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20240329xs8.htm S-8 82086
2 EX-5.1 tmb-20240329xex5d1.htm EX-5.1 10227
3 EX-23.2 tmb-20240329xex23d2.htm EX-23.2 1960
4 EX-FILING FEES tmb-20240329xexfilingfees.htm EX-FILING FEES 29032
5 GRAPHIC tmb-20240329xex5d1001.jpg GRAPHIC 2694
  Complete submission text file 0001558370-24-004330.txt   128296
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278363 | Film No.: 24802088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)